GSA Capital Partners’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,830
| Closed | -$420K | – | 1662 |
|
|
2024
Q1 | $420K | Sell |
22,830
-4,192
| -16% | -$77.1K | 0.03% | 999 |
|
|
2023
Q4 | $429K | Buy |
27,022
+20,173
| +295% | +$320K | 0.04% | 894 |
|
|
2023
Q3 | $129K | Buy |
+6,849
| New | +$129K | 0.01% | 1364 |
|
|
2021
Q2 | – | Sell |
-8,937
| Closed | -$475K | – | 1338 |
|
|
2021
Q1 | $475K | Sell |
8,937
-39
| -0.4% | -$2.07K | 0.08% | 384 |
|
|
2020
Q4 | $359K | Buy |
8,976
+7,684
| +595% | +$307K | 0.06% | 639 |
|
|
2020
Q3 | $74K | Buy |
+1,292
| New | +$74K | 0.01% | 1160 |
|